IMR Press / FBL / Volume 16 / Issue 5 / DOI: 10.2741/3819

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

The paradox of cancer cell apoptosis
Show Less
1 Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand

Academic Editor: Jang-Yang Chang

Front. Biosci. (Landmark Ed) 2011, 16(5), 1759–1767;
Published: 1 January 2011
(This article belongs to the Special Issue Recent investigations on the Inhibitors of apoptosis protein)

Resistance to apoptosis is an accepted property of human cancer cells and resistance to cancer therapy is often considered to involve increased resistance to apoptosis. However, comparison of the potential doubling times of human tumour cells with the volume doubling times of the tumour from which they are derived implies a high rate of apoptosis. For at least some cancer types, increased proliferation rate and correspondingly increased apoptosis is associated with a poor prognosis. How can resistance to apoptosis and apoptosis be reconciled? One possible resolution of this paradox is that at least two tumour cell populations are involved, a smaller, more rapidly growing population with self-renewal properties and resistance to apoptosis, and a larger, more slowly growing population that is susceptible to apoptosis. The progeny of smaller population thus maintains the larger population. This review describes the evidence for such a model and its implications for cancer therapy.

Back to top